Fatty Liver Face: Signs, Causes & What to Do (UK)

Published on: May 24, 2026

Medically reviewed by

Ashis Tandukar

Superintendent Pharmacist · Reg: GPhC No. 2084170

You've been studying your face in the bathroom mirror — the dull-looking skin, the small red spots that didn't used to be there, the puffiness under your eyes — and somewhere in the back of your mind, a thought you've been trying to ignore. Could this have something to do with my liver?

It's a fair question, and one we get asked surprisingly often. The short answer: sometimes yes, sometimes no — and what your face is telling you depends a lot on how far any liver problem has progressed. Most people with early fatty liver disease have no visible facial signs at all. But certain skin changes — a yellow tinge to the eyes, tiny spider-like vessels on the cheeks, dark velvety patches on the neck — can be quiet clues that the liver, or the metabolic problems often tangled up with it, need attention.

Can fatty liver really show up on your face?

Yes and no, and the nuance matters.

Fatty liver disease — what doctors now increasingly call metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD) — affects roughly one in three adults in the UK. For most of those people, the liver quietly accumulates excess fat without causing any symptoms at all. No tummy ache. No fatigue. And no skin changes.

This is part of what makes fatty liver disease so easy to miss. It's frequently picked up by accident — on an ultrasound being done for something else, or because liver enzymes came back unexpectedly raised on a routine blood test.

So when someone searches for "fatty liver face," what they're often picking up on are skin signs of more advanced liver dysfunction — the changes that occur once simple fat accumulation has progressed to inflammation (steatohepatitis, now called MASH), scarring (fibrosis), or cirrhosis. These changes can absolutely involve the face. But they typically aren't the first sign of a fatty liver — they're a sign that something has been going on for a while.

There's a second layer too. Many of the skin changes people associate with fatty liver aren't really caused by the liver at all. They're caused by the insulin resistance and metabolic syndrome that usually accompany MASLD. That's a meaningful distinction because it tells you where to look first — and where most of the treatment progress actually comes from.

The skin and facial signs worth knowing about

Here are the changes most strongly linked to liver dysfunction, and what each one actually tends to mean.

Jaundice — yellowing of the skin and the whites of the eyes

This is the one most people picture, and it's the most clinically important. Jaundice happens when bilirubin — a yellow-orange pigment your liver normally clears from the bloodstream — builds up in the body. The whites of the eyes (the sclerae) tend to go yellow first because the tissue there is thin and pale, making the colour change easier to see. The skin can follow.

Jaundice isn't a feature of simple fatty liver. It usually points to significant liver dysfunction — often advanced cirrhosis, an obstruction in the bile ducts, or hepatitis. If your skin or the whites of your eyes look yellow, particularly alongside dark urine, pale stools, fever or abdominal pain, this is not something to wait on. It needs same-day medical assessment, and the NHS recommends calling 111 or going to A&E.

Spider naevi (spider angiomas)

These are small, red, slightly raised lesions with thin blood vessels radiating outwards like a spider's legs. They're typically found on the upper body, neck and face — areas drained by the superior vena cava. A handful of spider naevi can be normal, especially in pregnancy or in children. But a cluster of new ones, particularly in an adult, can suggest the liver is struggling to clear oestrogen properly.

In advanced liver disease, impaired hormone metabolism leads to higher circulating oestrogen, which dilates small blood vessels under the skin. Like jaundice, spider naevi typically indicate progressive liver damage rather than simple steatosis.

Acanthosis nigricans — dark, velvety patches

This is one of the most telling skin signs of insulin resistance, and it's strongly linked with fatty liver disease (though, strictly speaking, it's not caused by the liver itself). Acanthosis nigricans shows up as dark, slightly thickened, velvety-textured patches in skin folds — the back and sides of the neck, the armpits, the groin, sometimes the knuckles.

If you've noticed your neck looking permanently grubby no matter how hard you scrub, that's often what's going on. It reflects elevated insulin levels driving the skin's pigment-producing cells. The connection with fatty liver is direct: insulin resistance is the metabolic engine behind both conditions.

Puffiness, dull skin and a tired-looking complexion

This is the symptom that brings most people to search for "fatty liver face" in the first place. The face appearing puffy or bloated, dull skin, a slightly sallow tone, dark or sunken-looking under-eyes.

Here we need to be honest: these are common, non-specific signs that can come from poor sleep, dehydration, alcohol use, stress, allergies and dozens of other causes. They aren't diagnostic of liver disease on their own. That said, in someone with established cirrhosis, a sallow, slightly yellow-grey complexion can develop — what older medical texts called a "hepatic facies." It tends to come with other clear signs of liver failure rather than appearing in isolation.

So if you're broadly well, eating reasonably, and only noticing some puffiness or dullness — it's far more likely you're tired, dehydrated or stressed than that your liver is failing. But if there are other risk factors or symptoms, it's worth a proper check.

Skin tags around the neck and eyelids

Soft, pendulous skin growths — often around the neck, armpits, eyelids and chest — are extremely common and usually harmless. Multiple skin tags, however, are another visible signpost of insulin resistance and metabolic syndrome, which often travel alongside fatty liver. A few skin tags aren't a problem. A sudden crop of them in someone with central weight gain and a strong family history of type 2 diabetes is worth flagging to your GP.

Xanthelasma — yellow plaques around the eyelids

Xanthelasma are soft, yellowish, fatty deposits that develop on or around the eyelids. They reflect underlying problems with cholesterol metabolism. They aren't specific to liver disease and can occur in people with otherwise normal liver function. However, in cholestatic liver disease — where bile flow is obstructed — cholesterol levels can climb high enough to trigger them. They're more typical of primary biliary cholangitis than of simple fatty liver.

Palmar erythema — reddened palms

Not strictly a "face" sign, but worth mentioning because it often appears in the same patients. The palms — especially the fleshy areas at the base of the thumb and little finger — take on a persistent reddish colour. Again, this points to chronic liver dysfunction rather than early fatty liver, and is often picked up by a GP on examination rather than noticed by the patient.

Why early fatty liver usually doesn't cause facial symptoms

This is the part that surprises people. The liver is a remarkable organ — it can be 80% damaged before it starts to fail in obvious ways, and it has enormous capacity to keep functioning even when significant amounts of it are full of fat. Simple steatosis (fat in the liver cells without much inflammation) often causes no symptoms at all, anywhere in the body.

It's only when the liver tips into the inflamed, scarred or cirrhotic stages that the metabolic, hormonal and detoxifying functions start to fail. At that point, problems with bilirubin clearance, oestrogen metabolism, clotting factor production and bile flow start showing up — including, sometimes, on the skin and face.

That's a useful framing because it means: if you've been told you have early fatty liver and you don't have any of the warning signs above, you've caught it at the best possible time. Reversibility is genuinely on the table.

The metabolic story behind the face

Here's where it gets interesting. The strongest links between fatty liver and visible facial signs run through metabolic syndrome — not through the liver itself.

Insulin resistance, which sits at the heart of MASLD, doesn't just store fat in the liver. It changes how the skin produces pigment (hence acanthosis nigricans). It promotes the growth of soft fibroepithelial polyps (skin tags). It raises levels of androgens, which can worsen adult acne and dull skin texture. It alters lipid handling, which can contribute to xanthelasma. And the obesity that frequently accompanies fatty liver can affect facial appearance through changes in fat distribution, fluid retention and inflammation.

So in many cases, the "face" of fatty liver isn't really showing you liver damage. It's showing you the underlying metabolic problem — and that's actually a more actionable signal than liver inflammation alone, because the metabolic side responds very well to weight loss and the right medical treatment. There's some overlap with the puffier, slightly altered look that can occur with weight gain itself, which is different again from the hollowed-out look of "Ozempic face" that some people develop with rapid weight loss.

When to see your GP

Many of the skin changes above can be caused by entirely benign things. But there are situations where you should book an appointment — and a small number where you should act urgently.

Book a non-urgent appointment with your GP if you notice:

• A new cluster of spider naevi, especially on the face, chest or neck
• New dark velvety patches in the folds of your neck, armpits or groin
• Multiple new skin tags appearing over a relatively short period
• Persistent, unexplained itching with or without a rash
• Yellowish plaques around the eyelids
• Persistent puffiness, sallow skin or fatigue alongside risk factors for liver disease (overweight, type 2 diabetes, high blood pressure, raised cholesterol, central weight gain, or significant alcohol use)

Seek urgent same-day assessment, or call 111, if you have:

• Yellowing of the whites of the eyes or the skin (jaundice)
• Dark, tea-coloured urine and pale stools
• Easy bruising or bleeding that seems out of proportion to a minor knock
• Severe abdominal pain, particularly in the upper right side
• Vomiting blood, or stools that are black and tarry
• Sudden confusion or significant drowsiness

These last symptoms can indicate acute liver failure or significant complications of cirrhosis and need immediate medical attention.

How fatty liver is actually diagnosed in the UK

If your GP suspects fatty liver, they'll typically take a focused history (alcohol use, medications, family history), examine you, and arrange some initial blood tests — liver function tests (LFTs), a full lipid profile, HbA1c or fasting glucose, and often a count of platelets and clotting markers. NICE guidance (specifically NG49) recommends using the FIB-4 score in primary care to estimate the risk of advanced fibrosis. It's a simple calculation using your age, AST, ALT and platelet count.

If your FIB-4 score is indeterminate or high, the next steps may include:

• An Enhanced Liver Fibrosis (ELF) blood test — a more specialised marker of scarring
• A liver ultrasound to confirm steatosis and check for structural problems
• Transient elastography (FibroScan) — a quick, painless test that measures liver stiffness and is the most useful non-invasive way to assess fibrosis
• In some cases, referral to a hepatologist for further assessment, including possible liver biopsy

The point of all this is to separate the very common, low-risk cases (simple steatosis in an otherwise healthy person) from the smaller group whose liver disease is progressing and needs more active management. Both groups benefit from treatment — but the urgency and intensity differ.

What actually reverses fatty liver

Now for the part that genuinely matters. Fatty liver — particularly MASLD — is one of the most reversible chronic conditions we treat, provided it hasn't progressed too far. And the cornerstone of reversal is weight loss.

The 5–10% rule

This is the figure to hold in your head. The evidence is consistent: losing 5% of your body weight reduces liver fat. Losing 7–10% can resolve inflammation (MASH) and even improve early fibrosis. Beyond 10%, you start to see meaningful regression of more established scarring in some patients.

For someone at 100 kg, that's 5–10 kg. For someone at 80 kg, it's 4–8 kg. Not nothing — but achievable, particularly with the right support.

Diet and movement that actually work

The evidence here doesn't point to a single magic diet. What matters most is sustained calorie reduction in a pattern you can maintain. A Mediterranean-style eating pattern — rich in vegetables, pulses, oily fish, olive oil and whole grains, lower in refined carbohydrates and sugary drinks — has the strongest evidence base for liver health.

Movement helps independently of weight loss. The NHS recommends at least 150 minutes of moderate-intensity activity per week, and even adding resistance training a couple of times a week makes a meaningful difference to insulin sensitivity. If you're starting from a low base, build gradually. Daily walking, getting off the bus a stop early, or a 20-minute home workout count.

Alcohol guidance should be individualised. The UK low-risk threshold is 14 units a week, spread over at least three days, but anyone with established fibrosis or cirrhosis will usually be advised to abstain entirely. Your clinician will guide this.

Medications that move the needle

For people who can't reach the 7–10% threshold through lifestyle alone — which is most people — medication is increasingly part of the conversation. GLP-1 receptor agonists (semaglutide, the active ingredient in Wegovy) and dual GIP/GLP-1 receptor agonists (tirzepatide, the active ingredient in Mounjaro) work by reducing appetite, slowing gastric emptying and improving insulin sensitivity. The weight loss they produce is significant — averaging around 15% with semaglutide and 20% or more with tirzepatide over 12 months in published trials.

The liver benefits are turning out to be substantial. In the SYNERGY-NASH Phase 2 trial, up to 73% of participants on tirzepatide achieved resolution of metabolic steatohepatitis (MASH) without worsening of fibrosis — figures that, if confirmed in Phase 3, would represent a meaningful step forward in MASLD treatment. Semaglutide showed similarly encouraging results in the ESSENCE trial, with MASH resolution in roughly 63% of treated patients.

These medications aren't currently licensed specifically for treating fatty liver in the UK. But they are licensed for weight management in adults who meet NICE criteria (typically a BMI over 30, or over 27 with weight-related health conditions), and the weight loss they produce drives most of the liver benefit. For many people with MASLD and obesity, that's the most realistic path to genuine reversal.

You can read more in our guides on Mounjaro safety, Wegovy cost in the UK, NHS eligibility for weight-loss injections, and the broader picture of weight loss medication options in 2026.

Treating the metabolic conditions that travel with fatty liver

Because MASLD rarely arrives alone, treating the company it keeps matters. That means optimising blood pressure control, getting HbA1c into range if you have type 2 diabetes, and managing cholesterol. Statins, contrary to a common misconception, are safe in fatty liver disease and shouldn't be withheld — they reduce cardiovascular risk significantly, which is what tends to kill people with MASLD long before liver failure does.

What about the skin signs themselves?

If you have visible signs you'd rather get rid of — spider naevi, for example, or yellow xanthelasma — there are cosmetic treatments available. Laser therapy and electrocautery can fade spider veins; xanthelasma can be removed surgically or with various ablative techniques. But these are second-order interventions. Treating the underlying condition first is what reduces the chance of new ones appearing.

Acanthosis nigricans typically improves slowly as insulin resistance improves. It doesn't disappear overnight, but with sustained weight loss and better blood sugar control, the patches gradually lighten over months.

A note on weight loss and facial appearance

Many of our patients ask, perfectly reasonably, what happens to their face when they lose a substantial amount of weight. The honest answer: it changes. Some changes are welcome — less puffiness, brighter-looking skin, the resolution of acanthosis nigricans, less under-eye darkness if metabolic markers improve. Others are less so — some people experience a more drawn or hollow appearance with rapid weight loss, particularly in the cheeks. We've written separately about losing face fat and what to do about Ozempic face if you'd like to read more.

The wider point is that for someone with fatty liver and visible metabolic skin changes, sustainable weight loss tends to be net positive for the face. The puffiness, dullness and pigmentation changes that drove the original concern often improve.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.